ELIGIBILITY CRITERIA - PHASE I (ARMS A, B, C): Patients with serious medical or psychiatric illness that in the opinion of the primary investigator is likely to interfere with study participation may not be enrolled
ELIGIBILITY CRITERIA - PHASE II (ARM D): Patients with serious medical or psychiatric illness that in the opinion of the primary investigator is likely to interfere with study participation may not be enrolled
Other illness or condition, including laboratory abnormalities, which in the opinion of the Investigator would exclude the patient from participating in this study. This includes, but is not limited to, serious medical conditions or psychiatric illness likely to interfere with participation in the study.
Serious medical or psychiatric illness likely to interfere with participation in this clinical study
Patient with serious medical of psychiatric illness likely to interfere with participation on this clinical study
Participant has a serious medical or psychiatric illness likely to interfere with participation in this clinical study.
Serious medical or psychiatric illness likely to interfere with participation in this clinical study
Serious medical or psychiatric illness likely to interfere with participation in this clinical study
Patient must not have serious medical or psychiatric illness likely to interfere with participation in this clinical study in the opinion of the investigator.
Serious medical or psychiatric illness likely to interfere with participation in this clinical study, in the opinion of the investigator
Active, uncontrolled serious infection or medical or psychiatric illness, that in the investigators opinion is likely to interfere with participation in this clinical trial
Serious medical or psychiatric illness likely to interfere with participation in this clinical study
Active, uncontrolled, serious infection, or medical, or psychiatric illness likely to interfere with participation in this clinic trial
Serious medical or psychiatric illness likely to interfere with participation in this clinical study
Patients must not have a serious medical or psychiatric illness likely to interfere with study participation
RANDOMIZED PHASE II (ARMS K AND L): Patients must not have a serious medical or psychiatric illness likely to interfere with study participation
Serious medical or psychiatric illness likely to interfere with participation in this clinical study
Serious medical or psychiatric illness likely to interfere with participation in this clinical study
Patients with serious medical or psychiatric illness likely to interfere with participation in this clinical study
Patients with serious medical or psychiatric illness likely to interfere with participation in this clinical study
Serious medical or psychiatric illness likely to interfere with participation in this clinical study
Serious medical or psychiatric illness likely to interfere with participation in this clinical study
Serious medical or psychiatric illness likely to interfere with participation in this clinical study
Patients with serious medical or psychiatric illness likely to interfere with participation in this clinical study
Serious medical or psychiatric illness likely to interfere with participation in this clinical study
Serious medical or psychiatric illness likely to interfere with participation in this clinical study
Patients must not have a serious medical or psychiatric illness likely to interfere with study participation
Serious medical or psychiatric illness likely to interfere with participation in this clinical study
Serious psychiatric illness or addiction likely to interfere with participation in this clinical study
Serious medical or psychiatric illness likely to interfere with participation in this clinical study
Patients with serious medical or psychiatric illness likely to interfere with participation in this clinical study
Serious medical or psychiatric illness likely to interfere with participation in this clinical study
Serious medical or psychiatric illness likely to interfere with participation in this clinical study
Serious medical or psychiatric illness likely to interfere with participation in this clinical study
Serious medical or psychiatric illness likely to interfere with participation in this clinical study
Serious medical or psychiatric illness likely to interfere with participation in this clinical study
Serious medical or psychiatric illness likely to interfere with participation in this clinical study.
No serious medical or psychiatric illness likely to interfere with participation in this clinical study
Serious medical or psychiatric illness likely to interfere with participation in this clinical study
Participant with a serious medical or psychiatric illness likely to interfere with participation in the study
Serious medical or psychiatric illness likely to interfere with participation in this clinical study
Concomitant medical or psychiatric illness that is likely to interfere with a reasonably safe execution of the treatment plan
Serious medical or psychiatric illness likely to interfere with participation in this clinical study
Patients with serious medical or psychiatric illness likely to interfere with participation in this clinical study
Serious medical or psychiatric illness likely to interfere with participation in this clinical study
Serious medical or psychiatric illness likely to interfere with participation in this clinical study
Serious medical or psychiatric illness likely to interfere with participation in this clinical study.
Serious medical or psychiatric illness likely to interfere with participation in this clinical study
Serious medical or psychiatric illness likely to interfere with participation in this clinical study per the judgment of the treating physician
Serious medical or psychiatric illness likely to interfere with participation in this clinical study
Serious medical or psychiatric illness likely to interfere with participation in this clinical study
Serious medical or psychiatric illness likely to interfere with participation in this clinical study
Serious medical or psychiatric illness likely to interfere with participation in this clinical study
Active, uncontrolled, serious infection or medical or psychiatric illness likely to interfere with participation in this clinic trial
Patients with a serious medical or psychiatric illness likely to interfere with participation in this clinical study
Patients with a serious medical or psychiatric illness likely to interfere with participation in this clinical study
Patients with a serious medical or psychiatric illness likely to interfere with participation in this clinical study
Subject has a serious medical or psychiatric illness likely to interfere with participation in this clinical study.
